JOHNSON DRNJOHNSON DRNJOHNSON DRN

JOHNSON DRN

No trades
See on Supercharts

Key facts today

Johnson & Johnson announced a cash dividend of $1.24 per share for Q1 2025, payable on March 4, 2025, to shareholders of record as of February 18, 2025, with the ex-dividend date on the same day.
Analyze the impactAnalyze the impact
Market capitalization
‪2.14 T‬BRL
0.00BRL
‪70.77 B‬BRL
‪425.32 B‬BRL
Beta (1Y)
−0.23

About Johnson & Johnson


CEO
Joaquin Duato
Headquarters
New Brunswick
Website
Founded
1887
ISIN
BRJNJBBDR002
FIGI
BBG0025NPG24
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US478160CT9
JOHNSON&JOHN 20/60
Yield to maturity
6.83%
Maturity date
Sep 1, 2060
US478160CS1
JOHNSON&JOHN 20/50
Yield to maturity
6.81%
Maturity date
Sep 1, 2050
US478160CR3
JOHNSON&JOHN 20/40
Yield to maturity
6.46%
Maturity date
Sep 1, 2040
US478160CM4
JOHNSON & JOHNSON 17/48
Yield to maturity
6.13%
Maturity date
Jan 15, 2048
US478160BV5
JOHNSON & JOHNSON 16/46
Yield to maturity
6.03%
Maturity date
Mar 1, 2046
JNJJ
JOHNSON & JOHNSON 17/47
Yield to maturity
5.99%
Maturity date
Mar 3, 2047
US478160CL6
JOHNSON & JOHNSON 17/38
Yield to maturity
5.59%
Maturity date
Jan 15, 2038
US478160CX0
JOHNSON&JOHN 24/54
Yield to maturity
5.49%
Maturity date
Jun 1, 2054
US478160CF9
JOHNSON & JOHNSON 17/37
Yield to maturity
5.47%
Maturity date
Mar 3, 2037
US478160BU7
JOHNSON & JOHNSON 16/36
Yield to maturity
5.45%
Maturity date
Mar 1, 2036
JNJ4077469
Johnson & Johnson 4.5% 05-DEC-2043
Yield to maturity
5.44%
Maturity date
Dec 5, 2043

Explore more bonds